DOLIPRANE
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79429858
- Mark type
- Stylized text
- Filed
- 17 Jun 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Jonathan M. Rixen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and dietary products for medical use, namely, preparations for use in the treatment of pain and fevers
Owner
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 05 Mar 2026 — NOTIFICATION PROCESSED BY IB
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Feb 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 12 Feb 2026 — REFUSAL PROCESSED BY IB
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 22 Jan 2026 — REFUSAL PROCESSED BY MPU
- 19 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 18 Dec 2025 — NON-FINAL ACTION WRITTEN